Follow
Thomas J. Kipps
Thomas J. Kipps
Professor of Medicine, UC San Diego
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin, CD Dumitru, M Shimizu, R Bichi, S Zupo, E Noch, H Aldler, ...
Proceedings of the national academy of sciences 99 (24), 15524-15529, 2002
71482002
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino, GA Calin, M Fabbri, MV Iorio, M Ferracin, M Shimizu, ...
Proceedings of the National Academy of Sciences 102 (39), 13944-13949, 2005
48852005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
39382008
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin, M Ferracin, A Cimmino, G Di Leva, M Shimizu, SE Wojcik, ...
New England Journal of Medicine 353 (17), 1793-1801, 2005
31622005
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ...
New England Journal of Medicine 370 (11), 997-1007, 2014
22022014
Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia
AW Roberts, MS Davids, JM Pagel, BS Kahl, SD Puvvada, JF Gerecitano, ...
New England Journal of Medicine 374 (4), 311-322, 2016
20482016
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
JC Byrd, JR Brown, S O'Brien, JC Barrientos, NE Kay, NM Reddy, ...
New England Journal of Medicine 371 (3), 213-223, 2014
19432014
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin, CG Liu, C Sevignani, M Ferracin, N Felli, CD Dumitru, ...
Proceedings of the National Academy of Sciences 101 (32), 11755-11760, 2004
17862004
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ...
New England Journal of Medicine 373 (25), 2425-2437, 2015
17202015
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018
16382018
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger, TJ Kipps
Blood 107 (5), 1761-1767, 2006
14892006
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ...
The Journal of experimental medicine 194 (11), 1639-1648, 2001
14402001
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ...
New England Journal of Medicine 351 (9), 893-901, 2004
12002004
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, SL Allen, P Schulman, ...
The Journal of clinical investigation 102 (8), 1515-1525, 1998
11291998
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1
JA Burger, N Tsukada, M Burger, NJ Zvaifler, M Dell'Aquila, TJ Kipps
Blood, The Journal of the American Society of Hematology 96 (8), 2655-2663, 2000
10112000
MiR-15a and miR-16-1 cluster functions in human leukemia
GA Calin, A Cimmino, M Fabbri, M Ferracin, SE Wojcik, M Shimizu, ...
Proceedings of the National Academy of Sciences 105 (13), 5166-5171, 2008
9952008
Venetoclax–rituximab in relapsed or refractory chronic lymphocytic leukemia
JF Seymour, TJ Kipps, B Eichhorst, P Hillmen, J D’Rozario, S Assouline, ...
New England Journal of Medicine 378 (12), 1107-1120, 2018
9612018
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
AW Roberts, JF Seymour, JR Brown, WG Wierda, TJ Kipps, SL Khaw, ...
Journal of Clinical Oncology 30 (5), 488, 2012
9402012
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas
GA Calin, C Liu, M Ferracin, T Hyslop, R Spizzo, C Sevignani, M Fabbri, ...
Cancer cell 12 (3), 215-229, 2007
9152007
Venetoclax and obinutuzumab in patients with CLL and coexisting conditions
K Fischer, O Al-Sawaf, J Bahlo, AM Fink, M Tandon, M Dixon, S Robrecht, ...
New England Journal of Medicine 380 (23), 2225-2236, 2019
8792019
The system can't perform the operation now. Try again later.
Articles 1–20